Cardiopulmonary bypass in neonates and infants: advantages of high flow high hematocrit bypass strategy—clinical practice review
Translational Pediatrics · 2023-07 · 12 (7) · 1431-1438
DOI: 10.21037/tp-23-94 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Translational Pediatrics, 2023-07. Verfasst von Karthik Ramakrishnan und 4 weiteren Autor:innen. Beteiligte Einrichtung: Division of Pediatric Cardiovascular Surgery, LeBonheur Children's Hospital, Memphis, TN, USA. Die Arbeit wurde bisher 18-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Division of Pediatric Cardiovascular Surgery, LeBonheur Children's Hospital, Memphis, TN, USA.
- Department of Surgery, University of Tennessee Health Sciences Center, Memphis, TN, USA.
- Division of Surgery, NYU Langone Hospital, New York, NY, USA.
Zitieren
APA
Ramakrishnan, K., Kumar, T. S., Boston, U. S., Allen, J., & Knott-Craig, C. J. (2023). Cardiopulmonary bypass in neonates and infants: advantages of high flow high hematocrit bypass strategy—clinical practice review. Translational Pediatrics, 12(7), 1431-1438. https://doi.org/10.21037/tp-23-94
Vancouver
Ramakrishnan K, Kumar TS, Boston US, Allen J, Knott-Craig CJ. Cardiopulmonary bypass in neonates and infants: advantages of high flow high hematocrit bypass strategy—clinical practice review. Translational Pediatrics. 2023;12(7):1431-1438. doi:10.21037/tp-23-94
BibTeX
@article{Ramakrishnan2023,
author = {Ramakrishnan, Karthik and Kumar, Tk Susheel and Boston, Umar S and Allen, Jerry and Knott-Craig, Christopher J},
title = {Cardiopulmonary bypass in neonates and infants: advantages of high flow high hematocrit bypass strategy—clinical practice review},
journal = {Translational Pediatrics},
year = {2023},
volume = {12},
number = {7},
pages = {1431--1438},
doi = {10.21037/tp-23-94}
}
EUVIMED